Mohammed Hiba, Kumar Ajay, Bekyarova Elena, Al-Hadeethi Yas, Zhang Xixiang, Chen Mingguang, Ansari Mohammad Shahnawaze, Cochis Andrea, Rimondini Lia
Biomaterials Lab, Department of Health Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy.
Biomaterials Lab, Interdisciplinary Research Center of Autoimmune Diseases, Center for Translational Research on Autoimmune and Allergic Diseases-CAAD, Novara, Italy.
Front Bioeng Biotechnol. 2020 May 25;8:465. doi: 10.3389/fbioe.2020.00465. eCollection 2020.
Bacterial infections represent nowadays the major reason of biomaterials implant failure, however, most of the available implantable materials do not hold antimicrobial properties, thus requiring antibiotic therapy once the infection occurs. The fast raising of antibiotic-resistant pathogens is making this approach as not more effective, leading to the only solution of device removal and causing devastating consequences for patients. Accordingly, there is a large research about alternative strategies based on the employment of materials holding intrinsic antibacterial properties in order to prevent infections. Between these new strategies, new technologies involving the use of carbon-based materials such as carbon nanotubes, fullerene, graphene and diamond-like carbon shown very promising results. In particular, graphene- and graphene-derived materials (GMs) demonstrated a broad range antibacterial activity toward bacteria, fungi and viruses. These antibacterial activities are attributed mainly to the direct physicochemical interaction between GMs and bacteria that cause a deadly deterioration of cellular components, principally proteins, lipids, and nucleic acids. In fact, GMs hold a high affinity to the membrane proteoglycans where they accumulate leading to membrane damages; similarly, after internalization they can interact with bacteria RNA/DNA hydrogen groups interrupting the replicative stage. Moreover, GMs can indirectly determine bacterial death by activating the inflammatory cascade due to active species generation after entering in the physiological environment. On the opposite, despite these bacteria-targeted activities, GMs have been successfully employed as pro-regenerative materials to favor tissue healing for different tissue engineering purposes. Taken into account these GMs biological properties, this review aims at explaining the antibacterial mechanisms underlying graphene as a promising material applicable in biomedical devices.
如今,细菌感染是生物材料植入失败的主要原因,然而,大多数现有的可植入材料不具备抗菌性能,因此一旦发生感染就需要进行抗生素治疗。抗生素耐药病原体的迅速增加使得这种方法不再有效,导致唯一的解决办法是移除装置,给患者带来毁灭性后果。因此,人们围绕基于使用具有内在抗菌性能的材料来预防感染的替代策略开展了大量研究。在这些新策略中,涉及使用碳纳米管、富勒烯、石墨烯和类金刚石碳等碳基材料的新技术显示出非常有前景的结果。特别是,石墨烯及其衍生材料(GMs)对细菌、真菌和病毒表现出广泛的抗菌活性。这些抗菌活性主要归因于GMs与细菌之间的直接物理化学相互作用,这种相互作用会导致细胞成分(主要是蛋白质、脂质和核酸)的致命性降解。事实上GMs对膜蛋白聚糖具有高亲和力,它们在膜蛋白聚糖上积累导致膜损伤;同样,内化后它们可以与细菌RNA/DNA的氢键相互作用,中断复制阶段。此外,GMs进入生理环境后会产生活性物质,激活炎症级联反应,从而间接导致细菌死亡。相反,尽管GMs具有这些针对细菌的活性,但它们已成功用作促进再生的材料,以利于不同组织工程目的的组织愈合。考虑到GMs的这些生物学特性,本综述旨在解释石墨烯作为一种适用于生物医学装置的有前景材料的抗菌机制。